Melanoma: Clinical sciences

1,044views

00:00 / 00:00

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 3 complete

A 47-year-old man presents to the dermatology clinic with concerns about a pigmented lesion on his left upper arm. He mentions that he first noticed the lesion about 6 months ago, but in the past two months, it appears to have grown and darkened in color. He works as a construction worker and often spends prolonged periods outdoors without sun protection. Past medical history is significant for hypertension controlled with hydrochlorothiazide. Family history is noncontributory. Temperature is 36.8°C (98.2°F), blood pressure is 130/85 mm Hg, pulse is 72/min, respiratory rate is 16/min, and oxygen saturation is 99% on room air. Skin examination reveals a 1.5 cm asymmetric lesion with an irregular border and with a number of variable colors. An excisional biopsy of the lesion reveals atypical melanocytes with hyperchromatic nuclei with a Breslow thickness of 0.7 mm, without ulceration, along with inadequate margins. There is no evidence of regional lymphadenopathy on examination. Which of the following is the best next step in management?  

Transcript

Watch video only

Melanoma is a very serious type of skin cancer arising from pigment-producing cells called melanocytes. It’s the fifth most common cancer in the United States and is associated with high rates of mortality. Melanoma can develop anywhere on the body and has a high rate of spread, so early diagnosis and treatment are key to improve overall outcomes.

Alright, when a patient presents with a chief concern suggesting melanoma, the first step is to obtain a focused history and physical. Typically, patients will report noticing a skin lesion with recent changes in size, color, or developing associated symptoms like pruritus. Sometimes they might even notice bleeding from the lesion.

A patient may also experience systemic symptoms that are alarming for malignancy, including fevers, chills, fatigue, bone pain, or weight loss. History might reveal risk factors like a personal or family history of cutaneous malignancy or immunosuppression, as well as fair skin, a tendency to sunburn, chronic sun exposure, or previous sunburns.

On a physical exam, you’ll typically find a pigmented skin lesion like a macule, plaque, or nodule with an irregular border. Make sure to do a full body exam checking for other similar lesions or nevi.

Important findings can be summarized by the mnemonic ABCDE, which stands for Asymmetry; Border irregularities; Color variations, such as brown or black spots with other colors like red, blue, gray, or white; Diameter, often larger than 6 mm; and Evolution, like changes in size, shape, or color, depigmentation, development of streaks, pseudopods or irregular vascularity.

Some of the suspicious characteristics you should look for include bleeding, crusting, or ulceration. If you see a lesion that differs from other nevi, it is called the "ugly duckling sign". Last but not least, remember to check regional lymph nodes for lymphadenopathy, which is concerning for possible metastasis. If you see these findings, be very suspicious of melanoma.

Here’s a clinical pearl! Primary care settings usually perform naked-eye physical examination, while dermatologic settings may also use support diagnostic tools like a dermatoscope, which acts as a magnifying glass to help evaluate the lesion in more detail.

The best way to confirm the diagnosis is with an excisional or incisional biopsy of the lesion, which will provide histopathological information. When possible, an excisional or complete biopsy should be performed to remove the entire lesion. This is done by taking 1 to 3 mm margin of surrounding normal skin, including the depth of the thickest part of the lesion. However, this might not be feasible if the lesion is large or located on the face, palms, or ears.

Sources

  1. "NCCN Guidelines® Insights: Melanoma: Cutaneous" J Natl Compr Canc Netw (2021)
  2. "Guidelines of care for the management of primary cutaneous melanoma" J Am Acad Dermatol (2019)
  3. "The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care" Expert Rev Anticancer Ther (2018)
  4. "Early detection of melanoma: reviewing the ABCDEs" J Am Acad Dermatol (2015)
  5. "AJCC Cancer Staging Manual, 8th ed" Springer International Publishing (2017)
  6. "Patterns of detection in patients with cutaneous melanoma" Cancer (2000)
  7. "Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma" Ann Surg (1970)
  8. "The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway" Arch Pathol Lab Med (2020)